4Life Transfer Factor ReCall
Natural health product licensed in Canada
- Licence holder
- 4Life Research Canada ULC
- NPN or DIN-HM
- 80047411
- Status
- Active licence
- Licence date
- 23 December 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 390 mg a day according to the dosing instructions published by Health Canada (10 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 390 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide L-alpha-acétamido-bêta-mercaptopropionique Source : N-Acétyl-L-cystéine | 17 mg | Not calculated |
| Melissa officinalis Source : Plante Extraction ratio : 4:1 Dry plant equivalent : 204 mg | 51 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extraction ratio : 50:1 Dry plant equivalent : 425 mg Potency : 24 % Flavonoid glycosides | 8.5 mg | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Magnésium Source : Oxyde de magnésium | 39 mg | 390,000 µg |
| Phosphatidyl sérine Source : Lécithine de soja enrichie en phosphatidylsérine | 23 mg | Not calculated |
| (bêta-hydroxyéthyl)triméthylammonium Source : Bitartrate de choline | 13.3 mg | Not calculated |
| Huperzia serrata Source : Sommité Extraction ratio : 100:1 Dry plant equivalent : 341 mg | 3.41 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, Gélatine, Cellulose microcristalline, Blanc d'oeuf, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 3 Capsule ; maximum: 10 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Lemon balm is traditionally used in Herbal Medicine as a sleep aid (in cases of restlessness or insomnia due to mental stress). Lemon balm is traditionally used in Herbal Medicine to help relieve digestive disturbances, such as dyspepsia. Helps the body to metabolize carbohydrates, fats and proteins. Helps in the development and maintenance of bones and teeth. Helps in tissue formation. Helps to maintain proper muscle function. A factor in the maintenance of good health. Helps to support liver function. Helps to enhance cognitive function in adults. Helps to enhance memory in adults. Helps to support peripheral circulation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80047411
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.